HRTX FY 2023 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HRTXHeron Therapeutics, Inc.

$162M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$127M+18.0% YoY

Gross Profit

$62M48.8% margin

Operating Income

-$111M-87.1% margin

Net Income

-$111M-87.0% margin

EPS (Diluted)

$-0.80

Cash Flow

Operating Cash Flow

-$59M

Free Cash Flow

-$60M

Stock-Based Comp.

$33M

Balance Sheet

Total Assets

$223M

Total Liabilities

$256M

Stockholders' Equity

-$34M

Cash & Equivalents

$29M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$127M	$108M	+18.0%
Gross Profit	$62M	$53M	+17.3%
Operating Income	-$111M	-$175M	+36.7%
Net Income	-$111M	-$182M	+39.3%